Experimental models of insulin resistance and obesity: Lessons learned;Modelos experimentais de resistência à insulina e obesidade: Lições aprendidas

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 50, Issue 2, 2006, Pages 190-197

  Ribeiro Cesaretti, Mario Luís ^a   Kohlmann Jr , Osvaldo ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Arterial hypertension; Insulin resistance; Leptin; Obesity

Indexed keywords

LEPTIN;

ADIPOSE TISSUE; ANIMAL; BIOLOGICAL MODEL; DIET; DISEASE MODEL; HYPERTENSION; INSULIN RESISTANCE; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ADIPOSE TISSUE; ANIMALS; DIET; DISEASE MODELS, ANIMAL; HYPERTENSION; INSULIN RESISTANCE; LEPTIN; MODELS, GENETIC; MODELS, IMMUNOLOGICAL; OBESITY;

EID: 33744462658     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302006000200005     Document Type: Review

References (49)

1. Zanella MT, Kohlmann Jr. O, Ribeiro AB. Treatment of obesity hypertension and diabetes syndrome. Hypertension 2001;38(3Pt2):705-8.
2. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;16-22;365:1415-28.
3. Kadowaki T. Insights into insulin resistance and type 2 diabetes from knockout mouse models. J Clin Invest 2000;106:459-65.
4. Pessin JE, Saltiel AR. Signaling pathways in insulin action: Molecular targets of insulin resistance. J Clin Invest 2000;106:165-9.
5. Bhanot S, McNeill JH. Insulin and Hypertension, a casual relationship? Cardiovascular Res 1996;31:212-21.
6. Correia ML, Haynes WG, Rahmouni K, Morgan DA, Sivitz WI, Mark AL. The concept of selective leptin resistance: Evidence from agouti yellow obese mice. Diabetes 2002;51:439-42.
7. Kose H, Moralejo DH, Ogino T, Mizuno A, Yamada T, Matsumoto K. Examination of OLETF-derived non-insulin-dependent diabetes mellitus QTL by construction of a series of congenic rats. Mamm Genome 2002;13:558-62.
8. Shaw AM, Irani BG, Moore MC, Haskell-Luevano C, Millard WJ. Ghrelin-induced food intake and growth hormone secretion are altered in melanocortin 3 and 4 receptor knockout mice. Peptides 2005;26:1720-7.
9. Plum L, Wunderlich FT, Baudler S, Krone W, Bruning JC. Transgenic and knockout mice in diabetes research: Novel insights into pathophysiology, limitations, and perspectives. Physiology (Bethesda) 2005;20:152-61.
10. Marques-Lopes I, Marti A, Moreno-Aliaga MJ, Martinez A. Genetics of obesity. Rev Nutr 2004;17/3:327-38.
11. Munzberg H, Myers Jr. MG. Molecular and anatomical determinants of central leptin resistance. Nat Neurosci 2005;8:566-70.
12. Campfield LA, Smith FJ, Burn P. The OB protein (leptin) pathway - a link between adipose tissue mass and central neural networks. Horm Metab Res 1996;28:619-32.
13. Keen Rhinehart E, Kalra SP, Kalra PS. Neuropeptidergic characterization of the leptin receptor mutated obese Koletsky rat. Regul Pept 2004;119(1-2):3-10.
14. Kanemoto N, Hishigaki H, Miyakita A, Oga K, Okuno S, Tsuji A, et al. Genetic dissection of "OLETF", a rat model for non-insulin-dependent diabetes mellitus. Mamm Genome 1998;9:419-25.
15. Sone H, Takahashi A, Iida K, Yamada N. Disease model: Hyperinsulinemia and insulin resistance. Part B - polygenic and other animal models. Trends Mol Med 2001;7:373-6.
16. Accili D, Drago J, Lee EJ, Johnson MD, Cool MH, Salvatore P, et al. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat Genet 1996;12:106-9.
17. Nandi A, Kitamura Y, Kahn CR, Accili D. Mouse models of insulin resistance. Physiol Rev 2004;84:623-47.
18. White MF. The insulin signalling system and the IRS proteins. Diabetologia 1997;40(suppl 2):S2-17.
19. Birnbaum MJ. Turning down insulin signaling. J Clin Invest 2001;108:655-9.
20. Pravenec M, Zidek V, Landa V, Simakova M, Mlejnek P, Kazdova L, et al. Genetic analysis of "metabolic syndrome" in the spontaneously hypertensive rat. Physiol Res 2004;53(suppl 1):S15-22.
21. Gouveia LM, Kettelhut IC, Foss MC. Abnormalities of glucose metabolism in spontaneously hypertensive rats. Braz J Med Biol Res 2000;33:1357-62.
22. Qi N, Kazdova L, Zidek V, Landa V, Kren V, Pershadsingh HA, et al. Pharmacogenetic evidence that cd36 is a key determinant of the metabolic effects of pioglitazone. J Biol Chem 2002;277:48501-7.
23. Sone H, Suzuki H, Takahashi A, Yamada N. Disease model: Hyperinsulinemia and insulin resistance. Part A - targeted disruption of insulin signaling or glucose transport. Trends Mol Med 2001;7:320-2.
24. Kurtz TW. Treating the metabolic syndrome: Telmisartan as a peroxisome proliferator-activated receptorgamma activator. Acta Diabetol 2005;42(suppl 1):S9-16.
25. Chiappe de Cingolani GE, Caldiz CI. Insulin resistance and GLUT-4 glucose transporter in adipocytes from hypertensive rats. Metabolism 2004;53:382-7.
26. Corry DB, Tuck ML. Obesity, hypertension, and sympathetic nervous system activity. Curr Hypertens Rep 1999;1:119-26.
27. Potenza MA, Marasciulo FL, Chieppa DM, Brigiani GS, Formoso G, Quon MJ, et al. Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production. Am J Physiol Heart Circ Physiol 2005;289:H813-22.
28. de Champlain J, Wu R, Girouard H, Karas M, El Midaoui A, Laplante MA, et al. Oxidative stress in hypertension. Clin Exp Hypertens 2004;26(7-8):593-601.
29. Ogihara T, Asano T, Ando K, Sakoda H, Anai M, Shojima N, et al. High-salt diet enhances insulin signaling and induces insulin resistance in Dahl salt-sensitive rats. Hypertension 2002;40:83-9.
30. Cesaretti M, Ginoza M, Shiguehara F, Kohlmann N, Tavares A, Zanella M, et al. Oral potassium overload reduces blood pressure and improves glucose metabolism in spontaneously hypertensive rats (SHR). J Hypertens 2000;18(suppl 4):S23.
31. Rahmouni K, Correia ML, Haynes WG, Mark AL. Obesity-associated hypertension: New insights into mechanisms. Hypertension 2005;45:9-14.
32. Correia ML, Haynes WG. Leptin, obesity and cardiovascular disease. Curr Opin Nephrol Hypertens 2004;13:215-23.
33. Kohlmann Jr. O, Neves FA, Ginoza M, Tavares A, Cesaretti ML, Zanella MT, et al. Role of bradykinin in insulin sensitivity and blood pressure regulation during hyperinsulinemia. Hypertension 1995;25:1003-7.
34. +) channel. Hypertension 2004;37:1028.
35. Moreno G, Perello M, Camihort G, Luna G, Console G, Gaillard RC, et al. Impact of transient correction of increased adrenocortical activity in hypothalamus-damaged, hyperadipose female rats. Int J Obes (London) 2005;[Epub ahead of print].
36. Lima MDA, Ginoza M, Tavares A, Dufloth D, Michelin L, Ribeiro A, et al. Methylprednisolone induced hypertension in rats - a role for diminished insulin sensitivity. Kidney Int 1994;46:1740.
37. Hirata AE, Andrade IS, Vaskevicius P, Dolnikoff MS. Monosodium glutamate (MSG)-obese rats develop glucose intolerance and insulin resistance to peripheral glucose uptake. Braz J Med Biol Res 1997;30:671-4.
38. Ferreira C, Cesaretti M, Ginoza M, Zanella M, Ribeiro A, Kohlmann O. Insulin sensitizers drugs administration to a rat model of the metabolic syndrome: Effects upon glucose metabolism and blood pressure. J Hypertens 2005;23(suppl 2):S238.
39. Vasdev S, Longerich L, Gill V. Prevention of fructoseinduced hypertension by dietary vitamins. Clin Biochem 2004;37:1-9.
40. Delbosc S, Paizanis E, Magous R, Araiz C, Dimo T, Cristol JP, et al. Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. Atherosclerosis 2005;179:43-9.
41. Al-Awwadi NA, Bornet A, Azay J, Araiz C, Delbosc S, Cristol JP, et al. Red wine polyphenols alone or in association with ethanol prevent hypertension, cardiac hypertrophy, and production of reactive oxygen species in the insulin-resistant fructose-fed rat. J Agric Food Chem 2004;52:5593-7.
42. de Paula RB, da Silva AA, Hall JE. Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration. Hypertension 2004;43:41-7.
43. Wofford MR, Hall JE. Pathophysiology and treatment of obesity hypertension. Curr Pharm Des 2004;10:3621-37.
44. da Silva AA, Kuo JJ, Tallam LS, Hall JE. Role of endothelin-1 in blood pressure regulation in a rat model of visceral obesity and hypertension. Hypertension 2004;43:383-7.
45. Pastore A, Cesaretti M, Ginoza M, Voltera A, Zanella MT, Ribeiro AB, et al. Effects of neuroendocrine and diet-induced obesity and its association, on glucose metabolism of Wistar rats. Int J Obesity 2004;28:S87.
46. Naderali EK, Pickavance LC, Wilding JP, Williams G. Diet-induced endothelial dysfunction in the rat is independent of the degree of increase in total body weight. Clin Sci (London) 2001;100:635-41.
47. Holemans K, Caluwaerts S, Poston L, Van Assche FA. Diet-induced obesity in the rat: A model for gestational diabetes mellitus. Am J Obstet Gynecol 2004;190:858-65.
48. Naderali EK, Fatani S, Williams G. Chronic withdrawal of a high-palatable obesity-inducing diet completely reverses metabolic and vascular abnormalities associated with dietary-obesity in the rat. Atherosclerosis 2004;172:63-9.
49. Kretschmer BD, Schelling P, Beier N, Liebscher C, Treutel S, Kruger N, et al. Modulatory role of food, feeding regime and physical exercise on body weight and insulin resistance. Life Sci. 2005;76:1553-73.